ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Education
Visit Zacks' Education section for investing guides and other free resources to make you a better investor.

Quote:

Search for Ticker

Free Membership

Search:

MAKO: Mako Surgical Corp - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

MAKO SURGICAL CORP (NASD)
MAKO	9.02	0.02	(0.22%)	Vol. 124,550	16:00 ET

MAKO SURGICAL CORP. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. MAKO's Tactile Guidance System includes an interactive tactile robotics-arm platform that utilizes tactile-guided robotics and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive tactile robotic-arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants.

General Information

MAKO SURGICAL

2555 Davie Road Ft Lauderdale, FL 33317 Phone: 954-927-2044 Fax: 954-927-0446 Web: www.makosurgical.com Email: None

Industry	MED INSTRUMENTS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	03/09/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	9.00
52 Week High	N/A
52 Week Low	6.18
Beta	-0.04
20 Day Moving Average	108,035.10
Target Price Consensus	11.67

% Price Change
4 Week	-1.96
12 Week	8.83
YTD	34.73

% Price Change Relative to S&P 500
4 Week	-5.71
12 Week	-1.76
YTD	9.03

Share Information
Shares Outstanding (millions)	32.13
Market Capitalization (millions)	289.21
Short Ratio	13.91
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	-0.27
Current Year EPS Consensus Estimate	-1.22
Estimated Long-Term EPS Growth Rate	40.00
Next EPS Report Date	03/09/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.33
30 Days Ago	2.33
60 Days Ago	2.33
90 Days Ago	2.00

Fundamental Ratios

P/E
Current FY Estimate:	-
Trailing 12 Months:	-
PEG Ratio	-

EPS Growth
vs. Previous Year	41.07%
vs. Previous Quarter	-26.92%

Sales Growth
vs. Previous Year	765.64%
vs. Previous Quarter:	-54.87%

Price Ratios
Price/Book	2.92
Price/Cash Flow	-
Price / Sales	10.99

ROE
09/30/09	-42.97
06/30/09	-70.30
03/31/09	-75.06

ROA
09/30/09	-36.78
06/30/09	-52.83
03/31/09	-57.60

Current Ratio
09/30/09	11.88
06/30/09	-
03/31/09	-

Quick Ratio
09/30/09	10.33
06/30/09	-
03/31/09	-

Operating Margin
09/30/09	-135.10
06/30/09	-178.30
03/31/09	-606.93

Net Margin
09/30/09	-
06/30/09	-
03/31/09	-

Pre-Tax Margin
09/30/09	-
06/30/09	-
03/31/09	-

Book Value
09/30/09	3.08
06/30/09	-
03/31/09	-

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	0.00
06/30/09	-
03/31/09	-

Debt to Capital
09/30/09	0.00
06/30/09	-
03/31/09	-


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research